The cytotoxic effect of some synthetic nitrogen-containing heterocyclic compounds on cultures of tumour and normal cells and the calculation of their ADME, QSAR, and DFT pharmacological properties
DOI:
https://doi.org/10.15587/2519-8025.2022.256113Keywords:
imidazoles, aurones, triazoles, MTT, ADME, QSAR, DFTAbstract
The cytotoxic effect of several synthetic nitrogen-containing heterocyclic compounds on cultures of tumour and normal cells and the calculation of their ADME, QSAR, and DFT pharmacological properties
The aim. The purpose of our work was to investigate the cytotoxic influence of some synthetic nitrogen-containing heterocyclic compounds, namely imidazole, aurones, and triazole on the culture of tumour cells of melanoma mouse B16, human glioma U251 and normal HEK293 and their ADME, QSAR, and DFT pharmacological properties calculation.
Materials and methods. The estimation of cell viability in the conditions of influence of the investigated drugs was carried out by MTT. ADME data screening was performed by the SWISSADME server. QSAR calculations were performed on Way2Drug servers (cancerogenicity was predicted with ROSC-Pred, metabolism – with RA, side effects of drugs were investigated using AdverPred server, LD50 were predicted with Gusar software). The calculation of the functional density (DFT) was carried out using B3LYP and the functional of the exchange-correlation with the base set of 6-31 G (D, P) in the MMFF94 force field in the Avogadro program.
The results. It was found that compounds 1 and 2 are toxic for normal cells HEK293, compounds 3, 4, 6 and 7 are low-toxic, and 5 does not inhibit cell growth at all. Our study has demonstrated that in the case of tumour cell line U251 compounds 2, 3 and 7 are non-toxic in general, and substances 1, 4, 5, 6 and 7 have significant toxicity. In a case of cancer cell line B16, compounds 1, 2, 4, 5, and 6 are toxic, and compound 7 is cytotoxic at any concentration. The test compounds (1–7) possess drug-like properties. All compounds meet Lipinski’s “rule of five” criteria. The BOILED-Egg model demonstrates that compound 3 may penetrate blood-brain barrier, all compounds except 1 can be absorbed in the intestine, 2 and 5 can be cleaved in the gastrointestinal tract and 3, 4, 6, and 7 have resistance to digestive enzymes. The analysis of metabolism showed that these compounds can mainly be metabolized by mechanisms of N- and O-glucuronidation and C-oxidation. The obtained data indicate that the smallest toxic effect is achieved with intravenously introduced compounds, and the largest toxicity is achieved with oral administration for compounds 3, 4, 5 and 6. The compounds 1 and 3 are completely noncarcinogenic, the other compounds can affect thyroid glands and hematopoietic system. This result requires further research when introduced into practical application. DFT calculations have shown that all investigated compounds are stable and reactive.
Conclusions. Differences in the sensitivity of cell lines and dose-dependent effects of compounds detected during the study should be considered when calculating the optimal working concentrations of drugs. The results of the study are necessary to understand toxic effects on the cell lines B16, HEK293, and U251 and their further use for preclinical studies
References
- Mohapatra, R. K., Saikishore, V. P., Azam, M., Biswal, S. K. (2020). Synthesis and physicochemical studies of a series of mixed-ligand transition metal complexes and their molecular docking investigations against Coronavirus main protease. Open Chemistry, 18 (1), 1495–1506. doi: http://doi.org/10.1515/chem-2020-0190
- Verma, A., Joshi, S., Singh, D. (2013). Imidazole: Having Versatile Biological Activities. Journal of Chemistry, 2013, 1–12. doi: http://doi.org/10.1155/2013/329412
- Mazziotti, I., Petrarolo, G., La Motta, C. (2021). Aurones: A Golden Resource for Active Compounds. Molecules, 27 (1), 2. doi: http://doi.org/10.3390/molecules27010002
- Boumendjel, A. (2003). Aurones: A Subclass of Flavones with Promising Biological Potential. Current Medicinal Chemistry, 10 (23), 2621–2630. doi: http://doi.org/10.2174/0929867033456468
- Boucherle, B., Peuchmaur, M., Boumendjel, A., Haudecoeur, R. (2017). Occurrences, biosynthesis and properties of aurones as high-end evolutionary products. Phytochemistry, 142, 92–111. doi: http://doi.org/10.1016/j.phytochem.2017.06.017
- Silva Torres, D., Alves de Oliveira, B., Souza d Silveira, L., Paulo da Silva, M., Rodrigues Durães Pereira, V., Moraes, J. et. al. (2021). Synthetic Aurones: New Features for Schistosoma mansoni Therapy. Chemistry & Biodiversity, 18 (11). doi: http://doi.org/10.1002/cbdv.202100439
- Haudecoeur, R., Boumendjel, A. (2012). Recent Advances in the Medicinal Chemistry of Aurones. Current Medicinal Chemistry, 19 (18), 2861–2875. doi: http://doi.org/10.2174/092986712800672085
- Roussaki, M., Costa Lima, S., Kypreou, A.-M., Kefalas, P., Cordeiro da Silva, A., Detsi, A. (2012). Aurones: A Promising Heterocyclic Scaffold for the Development of Potent Antileishmanial Agents. International Journal of Medicinal Chemistry, 2012, 1–8. doi: http://doi.org/10.1155/2012/196921
- Sutton, C. L., Taylor, Z. E., Farone, M. B., Handy, S. T. (2017). Antifungal activity of substituted aurones. Bioorganic & Medicinal Chemistry Letters, 27 (4), 901–903. doi: http://doi.org/10.1016/j.bmcl.2017.01.012
- Barmade, M. A., Ghuge, R. B.; Yadav, M. R., Murumkar, P. R., Ghuge, R. B. (2018). Vicinal Diaryl Heterocyclic System: A Privileged Scaffold in the Discovery of Potential Therapeutic Agents. Vicinal Diaryl Substituted Heterocycles, Elsevier, 1–20. doi: http://doi.org/10.1016/b978-0-08-102237-5.00001-8
- Mosmann, T. (1983). Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. Journal of Immunological Methods, 65 (1-2), 55–63. doi: http://doi.org/10.1016/0022-1759(83)90303-4
- Ghasemi, M., Turnbull, T., Sebastian, S., Kempson, I. (2021). The MTT Assay: Utility, Limitations, Pitfalls, and Interpretation in Bulk and Single-Cell Analysis. International Journal of Molecular Sciences, 22 (23), 12827. doi: http://doi.org/10.3390/ijms222312827
- Mosmann, T. (1983). Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. Journal of Immunological Methods, 65 (1-2), 55–63. doi: http://doi.org/10.1016/0022-1759(83)90303-4
- Daina, A., Zoete, V. (2016). A BOILED-Egg To Predict Gastrointestinal Absorption and Brain Penetration of Small Molecules. ChemMedChem, 11 (11), 1117–1121. doi: http://doi.org/10.1002/cmdc.201600182
- Daina, A., Michielin, O., Zoete, V. (2017). SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7 (1). doi: http://doi.org/10.1038/srep42717
- SwissADME. Available at: http://www.swissadme.ch/index.php
- Daina, A., Zoete, V. (2016). A BOILED-Egg To Predict Gastrointestinal Absorption and Brain Penetration of Small Molecules. ChemMedChem, 11 (11), 1117–1121. doi: http://doi.org/10.1002/cmdc.201600182
- Ivanov, S. M., Lagunin, A. A., Rudik, A. V., Filimonov, D. A., Poroikov, V. V. (2017). ADVERPred–Web Service for Prediction of Adverse Effects of Drugs. Journal of Chemical Information and Modeling, 58 (1), 8–11. doi: http://doi.org/10.1021/acs.jcim.7b00568
- Lahunin, A., Zakharov, A., Filimonov, D., Poroikov, V. (2011). QSAR Modeliuvannia hostroi toksychnosti shchuriv na osnovi prohnozu PASS. Mol. Informatyka, 30 (2-3), 241–250.
- Lagunin, A., Rudik, A., Druzhilovsky, D., Filimonov, D., Poroikov, V. (2017). ROSC-Pred: web-service for rodent organ-specific carcinogenicity prediction. Bioinformatics, 34 (4), 710–712. doi: http://doi.org/10.1093/bioinformatics/btx678
- Sacks, D., Baxter, B., Campbell, B., Carpenter, J. S., Cognard, C., Dippel, D. et. al. (2018). Multisociety Consensus Quality Improvement Revised Consensus Statement for Endovascular Therapy of Acute Ischemic Stroke. International journal of stroke, 13 (6), 612–632.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Vasyl Vdovin, Sergiy Yarmoluk
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.
Authors, who are published in this journal, agree to the following conditions:
1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons CC BY, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.
2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.